Yang Jim ^Investor

Experienced executive director and co-founder of BeiCell Therapeutics, a revolutionary cell therapy company in Beijing, China. Board member at OnCusp Therapeutics and Shanton Pharma in the United States. Member of the supervisory board at Innogen in Shanghai. Formerly worked at WuXi Biologics, Bristol Myers Squibb, and Hillhouse Capital Management. PhD in Oncology and Cancer Immunotherapy from the University of Southern California. Led investments in biotech and pharmaceutical companies at BioTrack Capital. Played a key role in developing the first anti-PD1 antibody in the world. Passionate about healthcare innovation and biopharma. Adept at due diligence, deal sourcing, and post-investment management.